Cargando…

Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) has become a global epidemic and is the third leading cause of death worldwide. COPD is characterized by chronic airway inflammation, loss of alveolar-capillary units, and progressive decline in lung function. Major risk factors for COPD are cigarette smo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Easter, Molly, Bollenbecker, Seth, Barnes, Jarrod W., Krick, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555616/ https://www.ncbi.nlm.nih.gov/pubmed/32967225 http://dx.doi.org/10.3390/ijms21186924

Ejemplares similares

429 Elevated Phosphate Levels Induce Lung Inflammation and Exacerbate Pulmonary Fibrosis
por: Bollenbecker, Seth, et al.
Publicado: (2022)

ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease
por: Krick, Stefanie, et al.
Publicado: (2021)

Fibroblast Growth Factor Signaling in Development and Disease
por: Bollenbecker, Seth, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 Signaling Does Not Increase Inflammation from Pseudomonas aeruginosa Infection in the Cystic Fibrosis Bronchial Epithelium
por: Hirsch, Meghan June, et al.
Publicado: (2023)

Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases
por: Garth, Jaleesa, et al.
Publicado: (2018)

Phosphate induces inflammation and exacerbates injury from cigarette smoke in the bronchial epithelium
por: Bollenbecker, Seth, et al.
Publicado: (2023)

A novel in vitro model to study prolonged Pseudomonas aeruginosa infection in the cystic fibrosis bronchial epithelium
por: Hirsch, Meghan J., et al.
Publicado: (2023)

An ex vivo rat trachea model reveals abnormal airway physiology and a gland secretion defect in cystic fibrosis
por: Harris, Elex, et al.
Publicado: (2023)

From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19
por: Guzy, Robert D., et al.
Publicado: (2022)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

The Effects of the Anti-aging Protein Klotho on Mucociliary Clearance
por: Garth, Jaleesa, et al.
Publicado: (2020)

Oxidative Stress in Chronic Obstructive Pulmonary Disease
por: Barnes, Peter J.
Publicado: (2022)

Chronic obstructive pulmonary disease and the hallmarks of aging
por: Kukrety, Shweta P., et al.
Publicado: (2018)

Fibroblast Growth Factor Receptor 4 Deficiency Mediates Airway Inflammation in the Adult Healthy Lung?
por: Easter, Molly, et al.
Publicado: (2020)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Targeted therapy in eosinophilic chronic obstructive pulmonary disease
por: Fieldes, Mathieu, et al.
Publicado: (2021)

O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension
por: Barnes, Jarrod W., et al.
Publicado: (2019)

Defining and targeting health disparities in chronic obstructive pulmonary disease
por: Pleasants, Roy A, et al.
Publicado: (2016)

Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
por: Edwards, Michael R., et al.
Publicado: (2009)

Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting
por: Barnes, Thomas A, et al.
Publicado: (2011)

Sirtuin 1 and Aging Theory for Chronic Obstructive Pulmonary Disease
por: Conti, V., et al.
Publicado: (2015)

Pulmonary embolism with chronic obstructive pulmonary disease
por: Yang, Ruohan, et al.
Publicado: (2021)

Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease
por: Barnes, Peter J, et al.
Publicado: (2004)

Autophagy in asthma and chronic obstructive pulmonary disease
por: Barnes, Peter J., et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs
por: Barnes, Peter J.
Publicado: (2010)

The genetics of chronic obstructive pulmonary disease
por: Wood, Alice M, et al.
Publicado: (2006)

Models of chronic obstructive pulmonary disease
por: Groneberg, David A, et al.
Publicado: (2004)

Genetics of chronic obstructive pulmonary disease
por: Seifart, Carola, et al.
Publicado: (2007)

The genetics of chronic obstructive pulmonary disease
por: Lomas, David A, et al.
Publicado: (2001)

Osteoporosis in Chronic Obstructive Pulmonary Disease
por: Sarkar, Malay, et al.
Publicado: (2015)

Telemedicine in chronic obstructive pulmonary disease
por: Ambrosino, Nicolino, et al.
Publicado: (2016)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease
por: Vijayan, V.K.
Publicado: (2013)

Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
por: Crisford, Helena, et al.
Publicado: (2018)

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
por: Marwick, John A, et al.
Publicado: (2010)

Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease
por: Fairley, Lauren H., et al.
Publicado: (2023)

The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease
por: Otu, Akaninyene, et al.
Publicado: (2023)

Aging and extrapulmonary effects of chronic obstructive pulmonary disease
por: Tudorache, Emanuela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dpiilmpikugphjc0bvnambd15e